Hatice Savas - Concepedia

Author

Hatice Savas

Northwestern University ORCID

Also Known As

Bennett, Richard, Hatice Savas, Savas H, Savas, Hatice

Publications

950

Citations

H-Index

Concepts

All Affiliations

Northwestern University Emory University University of Rochester Medical Center Rutgers, The State University of New Jersey Rutgers Cancer Institute

About

Hatice Savas is an author at Northwestern University specializing in medicine, oncology, and cancer therapeutics.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	2	2	44
2	Health Sciences	1	1	13
3	Hepatology	1	1	13
4	Immunology	1	1	31
5	Pathology	1	1	31

Hatice Savas

Publications

697

Citations

H-Index

Page 1

	Year	Citations
DeepCOVID-XR: An Artificial Intelligence Algorithm to Detect COVID-19 on Chest Radiographs Trained and Tested on a Large U.S. Clinical Data Set Ramsey M. Wehbe, Jiayue Sheng, Shinjan Dutta, Radiology	2020	184
Pembrolizumab followed by AVD in untreated early unfavorable and advanced-stage classical Hodgkin lymphoma Pamela B. Allen, Hatice Savas, Andrew M. Evens, Blood	2020	135
Frequent Monitoring of A1C During Pregnancy as a Treatment Tool to Guide Therapy Lois Jovanovič, Hatice Savas, Angelina Trujillo, Diabetes Care	2010	60
Tumor-Absorbed Dose Predicts Progression-Free Survival Following <sup>131</sup>I-Tositumomab Radioimmunotherapy Yuni K. Dewaraja, Matthew J. Schipper, Jincheng Shen, Journal of Nuclear Medicine	2014	57
Extraosseous Findings on Bone Scintigraphy Using Fusion SPECT/CT and Correlative Imaging Daniel J. Wale, Ka Kit Wong, Hatice Savas, American Journal of Roentgenology	2015	56
Pembrolizumab Added to Ifosfamide, Carboplatin, and Etoposide Chemotherapy for Relapsed or Refractory Classic Hodgkin Lymphoma Locke J. Bryan, Carla Casulo, Pamela B. Allen, JAMA Oncology	2023	55
SPECT/CT Evaluation of Unusual Physiologic Radioiodine Biodistributions: Pearls and Pitfalls in Image Interpretation Daniel I. Glazer, Richard K. Brown, Ka Kit Wong, Radiographics	2013	54
Sequential pembrolizumab and AVD are highly effective at any PD-L1 expression level in untreated Hodgkin lymphoma Pamela B. Allen, Xinyan Lu, Qing Chen, Blood Advances Positron Emission TomographyLymphoid NeoplasiaPd-l1 ExpressionMedicineUntreated Hodgkin Lymphoma	2022	31
A Framework for Harmonization of Radiomics Data for Multicenter Studies and Clinical Trials Moataz Soliman, Linda C. Kelahan, Michael Magnetta, JCO Clinical Cancer Informatics	2022	23
Pembrolizumab (PEM) Added to ICE Chemotherapy Results in High Complete Metabolic Response Rates in Relapsed/Refractory Classic Hodgkin Lymphoma (cHL): A Multi-Institutional Phase II Trial Locke J. Bryan, Carla Casulo, Pamela B. Allen, Blood	2021	18

Page 1